<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Senate Bill 166 Archives | Paradise Found</title>
	<atom:link href="https://paradisefoundor.com/category/senate-bill-166/feed/" rel="self" type="application/rss+xml" />
	<link>https://paradisefoundor.com/category/senate-bill-166/</link>
	<description>Medical Cannabis Dispensary in Portland, Oregon and Milwaukie, Oregon</description>
	<lastBuildDate>Tue, 07 May 2024 03:04:53 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.4</generator>
	<item>
		<title>Alaska House Approves Bill To Establish Task Force To Investigate Psychedelic Therapy</title>
		<link>https://paradisefoundor.com/alaska-house-approves-bill-to-establish-task-force-to-investigate-psychedelic-therapy/</link>
		
		<dc:creator><![CDATA[Jason]]></dc:creator>
		<pubDate>Tue, 07 May 2024 03:04:53 +0000</pubDate>
				<category><![CDATA[aggregated]]></category>
		<category><![CDATA[Alaska]]></category>
		<category><![CDATA[MDMA]]></category>
		<category><![CDATA[mental health]]></category>
		<category><![CDATA[news]]></category>
		<category><![CDATA[Psilocybin]]></category>
		<category><![CDATA[psychedelic therapy]]></category>
		<category><![CDATA[Psychedelics]]></category>
		<category><![CDATA[Senate Bill 166]]></category>
		<category><![CDATA[Task Force]]></category>
		<category><![CDATA[Veterans]]></category>
		<guid isPermaLink="false">https://paradisefoundor.com/alaska-house-approves-bill-to-establish-task-force-to-investigate-psychedelic-therapy/</guid>

					<description><![CDATA[<p>On May 2, the Alaska House of Representatives recently approved House Bill 228 in a 36-4 vote, which would establish a task [&#8230;]</p>
<p>The post <a href="https://paradisefoundor.com/alaska-house-approves-bill-to-establish-task-force-to-investigate-psychedelic-therapy/">Alaska House Approves Bill To Establish Task Force To Investigate Psychedelic Therapy</a> appeared first on <a href="https://paradisefoundor.com">Paradise Found</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div>
<p>On <a href="https://www.ktoo.org/video/gavel/house-floor-session-2024051035/?eventID=2024051035">May 2</a>, the Alaska House of Representatives recently approved <a href="https://www.akleg.gov/basis/Bill/Detail/33?Root=HB228">House Bill 228</a> in a 36-4 vote, which would establish a task force to regulate various psychedelic-assisted therapies. The official name of the group will be Alaska Task Force for the Regulation of Psychedelic Medicines Approved by the United States Food and Drug Administration.</p>
<p>Passing HB-228, according to Rep. Jenny Armstrong who sponsored the bill, is an attempt to get ahead of possible future substance rescheduling and/or federal approval. “This August, it is widely anticipated that FDA will approve the most significant medicine for the treatment of mental health in decades,” Armstrong said <a href="https://www.ktoo.org/video/gavel/house-floor-session-2024051035/?eventID=2024051035">prior to the House floor vote</a>. She added that FDA approval of psilocybin as a medical treatment could be coming in the next one to two years. “House Bill 228 before us today would create a task force that would put forth recommendations for the next legislature to consider as it relates to this treatment. Whether you are excited about the idea of psychedelics getting approved, you’re neutral or you’re flat-out against it, I think we can all agree that if it is coming, we should be prepared and be thoughtful in how we approach it.”</p>
<p>Armstrong also noted that Alaska not only has the most veterans per capita, but is also ranked among the highest in violence rates throughout the U.S. According to the <a href="https://cde.ucr.cjis.gov/LATEST/webapp/#/pages/explorer/crime/crime-trend">Federal Bureau of Investigation</a> data spanning 2012-2022, <a href="https://www.adn.com/alaska-news/crime-courts/2023/10/31/new-statewide-data-tells-mixed-story-about-crime-in-alaska/#:~:text=Alaska's%20violent%20crime%20rate%20remains,of%20Investigation's%20crime%20data%20explorer.">murder and aggravated assault</a> were among the top crimes reported in Alaska. While the total crime rate in 2021 and 2022 was reduced compared to numbers from 2018, murder incidents increased in 2019 and 2022.</p>
<p>If passed, HB-228 would require that a task force be established, and for the group to spend one year reviewing the pros and cons of psychedelic-assisted therapies such as psilocybin and MDMA.</p>
<p>Most House representatives were receptive to moving the bill forward to assist those who have mental health conditions. Rep. Laddie Shaw spoke up and explained that she was formerly the director of Alaskan Veteran Affairs, and veterans are asking for some kind of positive move forward. “This task force gives us an opportunity to move forward with some productivity on behalf of our veterans,” Shaw explained. “We haven’t done anything for the last 50 years. Let’s move forward with something.”</p>
<p>Rep. Sarah Vance also supported the bill, stating that even though she’s uncomfortable with the topic, she still sees the value in exploring psychedelic-assisted therapies as an option.</p>
<p>Other representatives, such as Rep. Dan Saddler, opposed the idea that there is any benefit to psychedelic drugs. “I rise against this bill because I don’t believe we should be going off in a direction in what I believe to be a premature fashion,” Saddler said. He added that a task force would encroach “on the purview of the legislature.”</p>
<p>Rep. Jamie Allard claimed that military veterans were being harmed by those attempting to promote psychedelic therapy agendas. “Using our military veterans as experiments? We aren’t experiments,” said Allard. “We are human beings who deserve to have things done in the proper manner, and slowly and concisely.”</p>
<p>Rep. David Eastman compared the approval of psychedelic medicine to the once normal acceptance of lobotomies. “I look at the history of medicine in this country, and it was not that long ago that we were told—and our entire government, you know, echoed—that lobotomies were a good thing, and they were carried out in our country,” said Eastman. “I hope that we will not look back some number of years now and see that hallucinogens were also a mistake.”</p>
<p>HB-228 received amendments one day before the House floor vote. On May 1, one of these changes included adding a board of directors member from the Alaska Pharmacy Association to the task force. Other changes include extending the due date of the task force report from December 31, 2024 to January 31, 2025. The task force was originally set to end at the beginning of the legislative session, but changes altered this timeline so that it would conclude at the end of the session instead. Another amendment required that any task force members from the Alaska State Medical Association must be physicians. “These are all items that we were looking to clean up with the other body if they weren’t tackled today and so I fully support them.” commented Armstrong.</p>
<p>The next move is for HB-228 to be presented to the Senate Judiciary Committee on May 6.</p>
<p><a href="https://www.akleg.gov/basis/Bill/Detail/33?Root=SB166">Senate Bill 166</a> is a companion bill to HB-228, introduced in January by sponsor Sen. Forrest Dunbar. At a Senate Labor &amp; Commerce committee hearing in February, Dunbar explained the purposes of the bill: “…the overriding purpose of the task force is still the same: We are preparing Alaska—hopefully preparing—for what we see as the very likely legalization, in the medical context, of certain of these substances,” <a href="https://www.akleg.gov/basis/Meeting/Detail/?Meeting=SL%26C%202024-02-16%2013:30:00&amp;Bill=SB%20166">Dunbar said</a>. </p>
<p><a href="https://hightimes.com/events/the-winners-of-the-high-times-cannabis-cup-alaska-peoples-choice-edition-2022/">Alaska</a> legalized medical cannabis through a voter initiative in 1998, and adult-use cannabis was later passed through a voter initiative in <a href="https://hightimes.com/news/alaska-becomes-3rd-state-with-legal-marijuana/">February 2015</a>.</p>
<p>The post <a href="https://hightimes.com/news/alaska-house-approves-bill-to-establish-task-force-to-investigate-psychedelic-therapy/">Alaska House Approves Bill To Establish Task Force To Investigate Psychedelic Therapy</a> first appeared on <a href="https://hightimes.com/">High Times</a>.</p>
</div>
<p>The post <a href="https://paradisefoundor.com/alaska-house-approves-bill-to-establish-task-force-to-investigate-psychedelic-therapy/">Alaska House Approves Bill To Establish Task Force To Investigate Psychedelic Therapy</a> appeared first on <a href="https://paradisefoundor.com">Paradise Found</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Alaska Lawmaker Introduces Psychedelics Task Force Bill</title>
		<link>https://paradisefoundor.com/alaska-lawmaker-introduces-psychedelics-task-force-bill/</link>
		
		<dc:creator><![CDATA[Jason]]></dc:creator>
		<pubDate>Wed, 31 Jan 2024 03:03:44 +0000</pubDate>
				<category><![CDATA[aggregated]]></category>
		<category><![CDATA[Alaska]]></category>
		<category><![CDATA[Anchorage]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Forrest Dunbar]]></category>
		<category><![CDATA[Governor Mike Dunleavy]]></category>
		<category><![CDATA[MAPS]]></category>
		<category><![CDATA[MDMA]]></category>
		<category><![CDATA[news]]></category>
		<category><![CDATA[Psilocybin]]></category>
		<category><![CDATA[Psychedelics]]></category>
		<category><![CDATA[Senate Bill 166]]></category>
		<category><![CDATA[Task Force]]></category>
		<guid isPermaLink="false">https://paradisefoundor.com/alaska-lawmaker-introduces-psychedelics-task-force-bill/</guid>

					<description><![CDATA[<p>An Alaska lawmaker has introduced a bill to create a task force to study the potential medical uses of psychedelic drugs including [&#8230;]</p>
<p>The post <a href="https://paradisefoundor.com/alaska-lawmaker-introduces-psychedelics-task-force-bill/">Alaska Lawmaker Introduces Psychedelics Task Force Bill</a> appeared first on <a href="https://paradisefoundor.com">Paradise Found</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div>
<p>An Alaska lawmaker has introduced a bill to create a task force to study the potential medical uses of psychedelic drugs including psilocybin and MDMA. The legislation, Senate Bill 166, was introduced earlier this month by Democratic state Senator Forrest Dunbar.</p>
<p>If passed by the legislature and signed into law by Republican Governor Mike Dunleavy, <a href="https://www.akleg.gov/basis/Bill/Detail/33?Root=SB%20166">Dunbar’s bill</a> would establish a task force that would be given one year to study how psychedelics might be used to address Alaska’s mental health challenges. The task force would investigate paths to legalize psychedelics, requirements for licensing and insurance, and barriers to access to the drugs.</p>
<p>“We want Alaska to have a regulatory framework to potentially allow medical providers to use the substances, which had been shown in sort of the early data of the tests to potentially have really positive impacts on people dealing with trauma and with addiction,” <a href="https://alaskapublic.org/2024/01/26/psychedelic-medicine-task-force-would-lay-groundwork-for-therapeutic-use-in-alaska/">Dunbar said</a> in a statement, according to a report from Alaska Public Media. </p>
<p>The psychedelics task force created by the legislation would consist of people representing the healthcare needs of Alaska Natives, military veterans and survivors of domestic abuse and sexual assault. Dunbar said it is important to include Alaska Natives in the task force, noting that other states have not included representation of Indigenous communities and traditional healers in their discussions about psychedelics policy reform.</p>
<p>Dunbar introduced Senate Bill 166 in anticipation of a potential change in the legal status of psychedelic drugs at the federal level. Clinical research and other studies into psychedelics such as psilocybin and MDMA have shown that the drugs have potential therapeutic benefits, particularly for serious mental health conditions such as <a href="https://www.forbes.com/sites/brucelee/2022/04/12/new-evidence-that-psilocybin-may-rewire-brain-to-help-those-with-depression/">depression</a>, PTSD, substance misuse disorders and <a href="https://www.forbes.com/health/mind/what-is-anxiety/">anxiety</a>. </p>
<p>“It doesn’t work for everyone, but there are certainly people who could access these substances and potentially have life changing medical results,” Dunbar said.</p>
<h2 id="psychedelic-research-shows-promise" class="wp-block-heading"><strong>Psychedelic Research Shows Promise</strong></h2>
<p>Research published in the peer-reviewed journal JAMA Psychiatry in 2020 found that psilocybin-assisted psychotherapy was an effective and quick-acting treatment for a group of 24 participants with major depressive disorder. A separate <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367557/">study</a> published in 2016 determined that psilocybin treatment produced substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer.</p>
<p>In 2017, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for psychotherapy utilizing MDMA, the psychedelic drug commonly known as Ecstasy, indicating that the therapy is a significant improvement over existing treatments. Last month, MAPS Public Benefit Corporation (MAPS PBC), a subsidiary of the groundbreaking psychedelics nonprofit advocacy group the Multidisciplinary Association for Psychedelic Studies (<a href="http://www.maps.org/">MAPS</a>), announced it had submitted an application seeking FDA approval for MDMA-assisted therapy. Only weeks later, the organization announced it had changed its name to Lykos Therapeutics and had raised $100 million in financing to develop psychedelic therapies.</p>
<p>As the research continues, Dunbar said it is important to address psychedelics policy including current prohibition and potential legalization so the drugs will be available to people who can benefit from them.</p>
<p>“The hope is because these are medical treatments that we would find a way to bill insurance like anything else,” Dunbar said. “How do we make sure we can bill Medicaid and bill private insurance? And I know the indigenous community in particular needs to think about, and will help guide the task force, so that we can make sure we’re getting funds into the traditional healers’ hands as well.”</p>
<p>Melissa Bradley, an epidemiologist based in Anchorage who studies psychedelic medicines, said that she became interested in the field after seeing the strong research data. She notes that psychedelic therapy is not an easy undertaking. Many patients find the experience challenging or upsetting during treatment, but long-lasting improvements in mental health have been reported for many patients. </p>
<p>Most research into the therapeutic potential of psychedelics is conducted in a controlled environment. Although the method is effective, finding ways to use the drugs in other, less controlled settings could be the key to greatly expanding access to psychedelic therapy. </p>
<p>“To really figure out the mystery of psychedelics is figuring out the mysteries of consciousness,” Bradley said. “And, we’re kind of poking at that, on the research side of things, but it’s also moving forward, in terms of policy. And so, it will be kind of a Wild West in terms of policy and regulations.”</p>
<p>Dunbar’s bill has been referred to the Senate Labor and Commerce Committee for consideration. Democratic State Representative Jennifer Armstrong has filed <a href="https://www.akleg.gov/basis/Bill/Detail/?Root=HB%20228">companion legislation</a> to Senate Bill 166 in the Alaska House of Representatives, where the measure has been assigned to the Health and Social Services Committee. No hearings have yet been planned for the bills, but Dunbar said he hopes to have one scheduled for early February.</p>
<p>The post <a rel="nofollow" href="https://hightimes.com/news/alaska-lawmaker-introduces-psychedelics-task-force-bill/">Alaska Lawmaker Introduces Psychedelics Task Force Bill</a> appeared first on <a rel="nofollow" href="https://hightimes.com/">High Times</a>.</p>
</div>
<p>The post <a href="https://paradisefoundor.com/alaska-lawmaker-introduces-psychedelics-task-force-bill/">Alaska Lawmaker Introduces Psychedelics Task Force Bill</a> appeared first on <a href="https://paradisefoundor.com">Paradise Found</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
